Skip to main content
Log in

Expression study of microRNA cluster on chromosome 19 (C19MC) in tumor tissue and serum of breast cancer patient

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Background

Breast cancer (BC) is the most prevalent cancer among females worldwide. Numerous studies suggest that specific RNAs play a crucial role in carcinogenesis. The primate-specific microRNA gene cluster located on the 19q27.3 region of chromosome 19 (C19MC) could potentially regulate tumor cell proliferation, migration, and invasion.

Objective

The objective of this study was to compare the expression of miRNAs from the C19MC cluster in breast cancer tumor and non-tumor samples, as well as in the serum of individuals affected by BC and healthy individuals.

Methods

Peripheral blood was collected from 100 BC patients and 100 healthy individuals, and breast cancer samples including tumor and margin tissues were obtained. After RNA extraction, Real-time PCR was employed to investigate the expression of C19MC, specifically mir-515–1, mir-515–2, mir-516-A1, mir-516-A2, mir-516-B1, mir-516-B2, mir-517-A, mir-517-B, mir-517-C, and mir-518-A1, in the serum and tissue of BC patients and tumor margins. Statistical analyses and ROC curves were generated using GraphPad Prism software (v8.04), with a significance level set at p < 0.05.

Results

Our findings demonstrate a strong correlation between high expression of all C19MC miRNAs mentioned, except for mir-517-B, mir-517-C and mir- 518 in BC. These miRNAs show potential as notable non-invasive tumor markers.

Conclusion

The data obtained from our study support the overall impact of C19MC miRNAs in BC detection and emphasize the potential role of several C19MC members in this process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

All data analyzed during this study are included in this published article. Further raw data from the current study are available from the corresponding author upon request.

References

  1. Gopinath A, Cheema AH, Chaludiya K, Khalid M, Nwosu M, Agyeman WY et al (2022) The impact of dietary fat on breast cancer incidence and survival: a systematic review. Cureus 14(10):e30003. https://doi.org/10.7759/cureus.30003. ((PubMed: 36381753))

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kolyvas EA, Caldas C, Kelly K, Ahmad SS (2022) Androgen receptor function and targeted therapeutics across breast cancer subtypes. Breast Cancer Res 24(1):79. https://doi.org/10.1186/s13058-022-01574-4. ((PubMed: 36376977))

    Article  PubMed  PubMed Central  Google Scholar 

  3. Chakrabortty A, Patton DJ, Smith BF, Agarwal P (2023) miRNAs: potential as biomarkers and therapeutic targets for cancer. Genes 14(7):1375. https://doi.org/10.3390/genes14071375

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Fridrichova I, Zmetakova I (2019) MicroRNAs contribute to breast cancer invasiveness. Cells 8(11):1361. https://doi.org/10.3390/cells8111361. ((PubMed: 31683635))

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Choo KB, Soon YL, Nguyen PNN, Hiew MSY, Huang CJ (2014) MicroRNA-5p and -3p co-expression and cross-targeting in colon cancer cells. J Biomed Sci 21:95

    Article  PubMed  PubMed Central  Google Scholar 

  6. Pan G, Liu Y, Shang L, Zhou F, Yang S (2021) EMT-associated microRNAs and their roles in cancer stemness and drug resistance. Cancer Commun (Lond) 41(3):199–217. https://doi.org/10.1002/cac2.12138. ((PubMed: 33506604))

    Article  PubMed  Google Scholar 

  7. Huang CJ, Nguyen PNN, Choo KB, Sugii S, Wee K, Cheong SK et al (2014) Frequent co-expression of miRNA-5p and -3p species and cross-targeting in induced pluripotent stem cells. Int J Med Sci 11:82

    Article  Google Scholar 

  8. Razak SRA, Ueno K, Takayama N, Nariai N, Nagasaki M, Saito R et al (2013) Profiling of microRNA in human and mouse ES and iPS cells reveals overlapping but distinct microRNA expression patterns. PLoS ONE 8:e73532

    Article  PubMed  PubMed Central  Google Scholar 

  9. Anokye-Danso F, Trivedi CM, Juhr D, Gupta M, Cui Z, Tian Y et al (2011) Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8:376–388

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zhang S, Shan C, Kong G, Du Y, Ye L, Zhang X (2012) MicroRNA-520e suppresses the growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK). Oncogene 31:3607–3620

    Article  CAS  PubMed  Google Scholar 

  11. Keklikoglou I, Koerner C, Schmidt C, Zhang JD, Heckmann D, Shavinskaya A et al (2012) MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor-negative breast cancer by targeting NF-κB and TGF-β signaling pathways. Oncogene 31:4150–4163

    Article  CAS  PubMed  Google Scholar 

  12. Kleinman CL, Gerges N, Papillon-Cavanagh S, Sin-Chan P, Pramatarova A, Quang D-AK et al (2014) Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR. Nat Genet 46:39–44

    Article  CAS  PubMed  Google Scholar 

  13. Cui W, Zhang Y, Hu N, Shan C, Zhang S, Zhang W et al (2010) miRNA-520b and mir-520e sensitize breast cancer cells to complement attack via directly targeting 3’UTR of CD46. Cancer Biol Ther 10:232–241

    Article  CAS  PubMed  Google Scholar 

  14. Min D, Lv X, Wang X, Zhang B, Meng W, Yu F et al (2013) Downregulation of mir-302c and mir-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumor cells to natural killer cell-mediated cytotoxicity. Br J Cancer 109:723–730

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Su C-M, Wang M-Y, Hong C-C, Chen H-A, Su Y-H, Wu C-H et al (2016) mir-520h is crucial for DAPK2 regulation and breast cancer progression. Oncogene 35(9):1134–1142

    Article  CAS  PubMed  Google Scholar 

  16. Zhang J, Liu L, Sun Y, Xiang J, Zhou D, Wang L et al (2016) MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression. Oncotarget 7:26516–26534

    Article  PubMed  PubMed Central  Google Scholar 

  17. Wang J, Haubrock M, Cao K-M, Hua X, Zhang C-Y, Wingender E et al (2011) Regulatory coordination of clustered microRNAs based on microRNA-transcription factor regulatory network. BMC Syst Biol 5:199

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Lin S, Cheung WKC, Chen S, Lu G, Wang Z, Xie D et al (2010) Computational identification and characterization of primate-specific microRNAs in the human genome. Comput Biol Chem 34:232–241

    Article  CAS  PubMed  Google Scholar 

  19. Zhou J-Y, Zheng S-R, Liu J, Shi R, Yu H-L, Wei M (2016) Mir-519d facilitates the progression and metastasis of cervical cancer through direct targeting Smad7. Cancer Cell Int 16:21

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kan H, Guo W, Huang Y, Liu D (2015) MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7. FEBS Lett 589:102–109

    Article  CAS  PubMed  Google Scholar 

  21. Noguer-Dance M, Abu-Amero S, Al-Khtib M, Lefe A, Coullin P, Moore GE (2010) The primate-specific microRNA gene cluster (C19MC) is imprinted in the placenta. Hum Mol Genet 19:3566–3582

    Article  CAS  PubMed  Google Scholar 

  22. Sugii S, Kida Y, Berggren WT, Evans RM (2011) Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells. Nat Protoc 6:346–358

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Choo KB, Tai L, Hymavathee KS, Wong CY, Nguyen PNN, Huang CJ et al (2014) Oxidative stress-induced premature senescence in Wharton’s jelly-derived mesenchymal stem cells. Int J Med Sci 11:1201–1207

    Article  PubMed  PubMed Central  Google Scholar 

  24. Ma W, Yu Q, Jiang J, Du X, Huang L, Zhao L et al (2016) mir-517a is an independent prognostic marker and contributes to cell migration and invasion in human colorectal cancer. Oncol Lett 11:2583–2589

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ren G, Wang L (2016) Study on the relationship between mir-520g and the development of breast cancer. Eur Rev Med Pharmacol Sci 20:657–663

    PubMed  Google Scholar 

  26. Tsai C-H, Tsai H-C, Huang H-N, Hung C-H, Hsu C-J, Fong Y-C et al (2014) Resistin promotes tumor metastasis by down-regulation of mir-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells. Oncotarget 6:258–270

    Article  PubMed Central  Google Scholar 

  27. Brownlie RJ, Zamoyska R (2013) T cell receptor signaling networks: branched, diversified and bounded. Nat Rev Immunol 13:257–269

    Article  CAS  PubMed  Google Scholar 

  28. Danielsen SA, Eide PW, Nesbakken A, Guren T, Leithe E, Lothe RA (2015) Portrait of the PI3K/AKT pathway in colorectal cancer. Biochim Biophys Acta 1855:104–121

    CAS  PubMed  Google Scholar 

  29. Guan R, Cai S, Sun M, Xu M (2017) Upregulation of miR-520b promotes ovarian cancer growth. Oncol Lett 14:3155–3161. https://doi.org/10.3892/ol.2017.6552

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Hu N, Zhang J, Cui W, Kong G, Zhang S, Yue L, Bai X, Zhang Z, Zhang W, Zhang X, Ye L (2011) miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8. J Biol Chem 286(15):13714–13722

    Article  Google Scholar 

  31. Menon A, Abd-Aziz N, Khalid K, Poh CL, Naidu R (2022) miRNA: a promising therapeutic target in cancer. Int J Mol Sci 23(19):11502. https://doi.org/10.3390/ijms231911502

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Li M, Lee KF, Lu Y, Clarke I, Shih D, Eberhart C et al (2009) Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell 16:533–546

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Flor I, Neumann A, Freter C, Helmke BM, Langenbuch M, Rippe V et al (2012) Abundant expression and hemimethylation of C19MC in cell cultures from placenta-derived stromal cells. Biochem Biophys Res Commun 422:411–416

    Article  CAS  PubMed  Google Scholar 

  34. Pinho FG, Frampton AE, Nunes J (2013) Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation. Can Res 73:5936–5948

    Article  CAS  Google Scholar 

  35. Jagadeeswaran G, Zheng Y, Sumathipala N, Jiang H, Arrese EL, Soulages JL et al (2010) Deep sequencing of small RNA libraries reveals dynamic regulation of conserved and novel microRNAs and microRNA-stars during silkworm development. BMC Genomics 11:1–18

    Article  Google Scholar 

  36. Li S-C, Liao Y-L, Ho M-R, Tsai K-W, Lai C-H, Lin W (2012) miRNA arm selection and isomiR distribution in gastric cancer. BMC Genomics 13(Suppl 1):S13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Carroll AP, Goodall GJ, Liu B (2014) Understanding principles of miRNA target recognition and function through integrated biological and bioinformatics approaches. Wiley Interdisc Rev 5:361–379

    Article  CAS  Google Scholar 

  38. Akbari Moqadam F, Pieters R, den Boer ML (2013) The hunting of targets: challenge in miRNA research. Leukemia 27:16–23

    Article  CAS  PubMed  Google Scholar 

  39. Jalvy-Delvaille S, Maurel M, Majo V, Pierre N, Chabas S, Combe C et al (2012) Molecular basis of differential target regulation by mir-96 and mir-182: the glypican-3 as a model. Nucleic Acids Res 40:1356–1365

    Article  CAS  PubMed  Google Scholar 

  40. Bar M, Wyman SK, Fritz BR, Qi J, Garg KS, Parkin RK et al (2008) MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries. Stem Cells 26:2496–2505

    Article  CAS  PubMed  Google Scholar 

  41. Portt L, Norman G, Clapp C, Greenwood M, Greenwood MT (2011) Anti-apoptosis and cell survival: a review. Biochem Biophys Acta 1813:238–259

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all patients and individuals for participating in this project.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

SARA Experimented and wrote the manuscript with support from MH and MAHF. MH supervised the work and contributed to the design and implementation of the research, the analysis of the results, and the writing of the manuscript. MAHF Helped supervise the project. All authors discussed the results and contributed and reviewed the final manuscript.

Corresponding author

Correspondence to Mehdi Haghi.

Ethics declarations

Competing interest

The authors confirm that there are no known conflicts of interest associated with this publication, and there has been no significant financial support for this work that could have influencedits outcome.

Ethical approval

This study was approved by the Department of Biology committee at the University of Tabriz (14000907–198-7).

Consent to participate

All stages of sample collection have been done with the consent of patients and healthy people, and written consent forms have been obtained.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Altalebi, S.A.R., Haghi, M. & Hosseinpour Feizi, M.A. Expression study of microRNA cluster on chromosome 19 (C19MC) in tumor tissue and serum of breast cancer patient. Mol Biol Rep 50, 9825–9831 (2023). https://doi.org/10.1007/s11033-023-08801-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-023-08801-x

Keywords

Navigation